MDXG · Mimedx Group Inc
United States · RS rating 20 · As of 2026-11-03
| Price | 3.25 USD |
|---|---|
| 1-day change | -0.9% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 13 / 29 / 18 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 12 / 15 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -9.1% |
| Sales growth Q/Q | +3.8% |
| Distance from 52-week high | +59.2% |
| Market cap (USD) | $497.7M |